register

Medical

#CytivaThinkPink: Cytiva to donate part of its October sales to breast cancer research

Health Industry Hub | October 7, 2020 |

Every year, Cytiva, a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics, joins the global fight against breast cancer through its #CytivaThinkPink campaign which is dedicated to supporting the Breast Cancer Research Foundation (BCRF).

For its fourth edition in 2020, the campaign aims to fund 3,300 hours of breast cancer research, 900 more compared to the previous year.

Throughout October 2020, Cytiva will donate $1 to BCRF for every purchase of Mab-Select chromatography resins, Whatman filter papers, Sera-Mag Select reagents and Amersham nitrocellulose membranes. These products are critical in accelerating cancer research and drug development programs.

Emmanuel Abate, Vice President and Head of Genomics and Cellular Research, Cytiva, said “The most common form of cancer in women, breast cancer can have an impact on all of us. People affected by it can be our family members, friends or colleagues. Even while coping with the COVID-19 pandemic, cancer doesn’t slow down and no one can beat this disease alone. We proudly continue to make diagnostic kits, consumables, and instruments used to enable cancer research, and are excited to once again devote time, energy and donations to the important work done by BCRF.”

For Janelle Bryce, Marketing Leader for Australia and New Zealand, the implications of supporting breast cancer research are personal.

“As a breast cancer survivor, I believe that it is crucial to help eliminate the suffering that this debilitating disease brings upon so many of us. research and biotechnology can help save millions of lives when better detection and treatment options are available,” said Ms Bryce.

Breast cancer affects 2.1 million women every year. BCRF is the largest private funder of breast cancer research worldwide, supporting programs on prevention, tumour biology, genetics, treatment, metastasis and survivorship.

In 2020, the #CytivaThinkPink campaign takes place across Australia and New Zealand, United States, Canada, Europe and China. For more information, please visit the Cytiva website.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.